{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:33:10Z","timestamp":1792236790680,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1992,3,1]],"date-time":"1992-03-01T00:00:00Z","timestamp":699408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":8676,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1992,3]]},"DOI":"10.1111\/1523-1747.ep12499784","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T14:29:18Z","timestamp":1089901758000},"page":"310-314","source":"Crossref","is-referenced-by-count":14,"title":["Cutaneous Metabolism of Theophylline by the Human Skin"],"prefix":"10.1016","volume":"98","author":[{"given":"John I","family":"Ademola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard I","family":"Maibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12499784_bb0010","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJM197506052922305","article-title":"Dosage of theophylline in bronchial asthma","volume":"292","author":"surname","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1111\/1523-1747.ep12499784_bb0015","first-page":"22","article-title":"Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease","volume":"131","author":"Mahler","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/1523-1747.ep12499784_bb0020","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/adc.53.7.598","article-title":"Weaning very low birth weight infants from mechanical ventilation using intermittent mandatory ventilation and theophylline","volume":"53","author":"Barr","year":"1976","journal-title":"Arch Dis Child"},{"key":"10.1111\/1523-1747.ep12499784_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(78)80084-5","article-title":"Physiologic changes induced by theophylline in the treatment of apnea in preterm infants","volume":"92","author":"Davi","year":"1978","journal-title":"J Pediatr"},{"key":"10.1111\/1523-1747.ep12499784_bb0030","first-page":"33","article-title":"Effects of aminophylline on ventilatory respiratory responses in normal men","volume":"117","author":"Lakshminarayan","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/1523-1747.ep12499784_bb0035","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1378\/chest.88.2_Supplement.91S","article-title":"Effects of theophylline on respiratory muscle function","volume":"88","author":"Aubier","year":"1985","journal-title":"Chest"},{"key":"10.1111\/1523-1747.ep12499784_bb0040","first-page":"1","article-title":"Theophylline: an overview","volume":"22","author":"Bukowskyi","year":"1985","journal-title":"Rational drug therapy"},{"key":"10.1111\/1523-1747.ep12499784_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1378\/chest.92.1_Supplement.22S","article-title":"Favourable cardiovascular effects of theophylline in Chronic obstructive pulmonary disease","volume":"92","author":"Matthay","year":"1987","journal-title":"Chest"},{"key":"10.1111\/1523-1747.ep12499784_bb0050","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1248\/cpb.35.2079","article-title":"Studies on the temporal variations in the pharmacokinetics and metabolism of theophylline","volume":"35","author":"Hasegawa","year":"1987","journal-title":"Chem Pharm Bull"},{"key":"10.1111\/1523-1747.ep12499784_bb0055","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2165\/00003088-198815060-00003","article-title":"Pharmakokinetics of theophyiline and its metabolites in a patient undergoing continuous ambulatory peritoneal dialysis","volume":"15","author":"Vree","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/1523-1747.ep12499784_bb0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9258(18)70714-X","article-title":"A study of the metabolism of theobromine, theophylline and caffeine in man","volume":"228","author":"Cornish","year":"1957","journal-title":"J Biol Chem"},{"key":"10.1111\/1523-1747.ep12499784_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2125.1983.tb01475.x","article-title":"Atwood: Secondary metabolism of theophylline biotransformation products in man: rate of formation of 1-methyl uric acid","volume":"15","author":"Birkette","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/1523-1747.ep12499784_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/cpt1972133349","article-title":"Pharmcokinetics of theophylline","volume":"13","author":"Jenne","year":"1972","journal-title":"Clin Pharm Ther"},{"key":"10.1111\/1523-1747.ep12499784_bb0075","first-page":"93","article-title":"Animal models for cutaneous drug metabolizing enzymes","volume":"III","author":"Goerz","year":"1987"},{"key":"10.1111\/1523-1747.ep12499784_bb0080","first-page":"267","article-title":"Determination of percutaneous absorption by in vitro techniques","volume":"6","author":"Bronaugh","year":"1985"},{"key":"10.1111\/1523-1747.ep12499784_bb0085","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/0006-2952(89)90075-0","article-title":"Characterisation of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin","volume":"38","author":"Pham","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/1523-1747.ep12499784_bb0090","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0041-008X(89)90160-9","article-title":"Extent of cutaneous metabolism during percutaneous absorption of xenobiotics","volume":"99","author":"Bronaugh","year":"1989","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1111\/1523-1747.ep12499784_bb0095","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/0006-2952(88)90402-9","article-title":"Caffeine and theophylline metabolism in newborn and adult human hepatocytes; comparison with adult rat hepatocytes","volume":"37","author":"Berthou","year":"1988","journal-title":"Biochem Pharmcol"},{"key":"10.1111\/1523-1747.ep12499784_bb0100","first-page":"3","article-title":"Products of metabolism of caffeine","author":"Arnaud","year":"1984"},{"key":"10.1111\/1523-1747.ep12499784_bb0105","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1126\/science.515734","article-title":"Metabolism of theophylline to caffeine in human fetal liver","volume":"206","author":"Aranda","year":"1979","journal-title":"Science"},{"key":"10.1111\/1523-1747.ep12499784_bb0110","first-page":"213","article-title":"Theophylline metabolism by the rat liver microsomal system","volume":"196","author":"Lohman","year":"1976","journal-title":"J Clin Pharmacol Exp Ther"},{"key":"10.1111\/1523-1747.ep12499784_bb0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2125.1987.tb03172.x","article-title":"Characterisation of theophylline metabolism in human liver microsomes","volume":"24","author":"Robson","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/1523-1747.ep12499784_bb0120","first-page":"201","article-title":"Outward transdermal migration of theophylline","volume":"1","author":"Peck","year":"1987","journal-title":"Pharmacol Skin"},{"key":"10.1111\/1523-1747.ep12499784_bb0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2125.1983.tb01521.x","article-title":"Determination of the plasma protein binding of theophylline in health","volume":"15","author":"Buss","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/1523-1747.ep12499784_bb0130","first-page":"1505","volume":"2","author":"Cooper","year":"1982"},{"key":"10.1111\/1523-1747.ep12499784_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0378-5173(88)90053-1","article-title":"Altered skin permeation of a highly lipophilic molecule: tetra hydrocannabind","volume":"43","author":"Touitou","year":"1988","journal-title":"Int J Pharm"},{"key":"10.1111\/1523-1747.ep12499784_bb0140","first-page":"637","article-title":"The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline","volume":"4","author":"Caldwell","year":"1979","journal-title":"Br J Clin Toxicol"},{"key":"10.1111\/1523-1747.ep12499784_bb0145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1600-0773.1977.tb02106.x","article-title":"Respiratory and cardiovascular effects of 3-methylxanthines, a metabolite of theophylline","volume":"49","author":"Persson","year":"1977","journal-title":"Acta Pharmacol Toxicol"},{"key":"10.1111\/1523-1747.ep12499784_bb0150","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/clpt.1984.23","article-title":"Theophylline metabolism: variation and genetics","volume":"35","author":"Miller","year":"1984","journal-title":"Clin Pharm Ther"},{"key":"10.1111\/1523-1747.ep12499784_bb0155","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/jps.2600791207","article-title":"Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles","volume":"79","author":"Bruce","year":"1990","journal-title":"J Pharm Sciences"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9290088L?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X9290088L?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T21:48:36Z","timestamp":1705182516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X9290088L"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1992,3]]}},"alternative-id":["S0022202X9290088L"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12499784","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}